Important Safety Information:
CONTRAINDICATIONS: ELOCTATE is contraindicated in patients who have had life-threatening hypersensitivity reactions to ELOCTATE or its excipients.
WARNINGS AND PRECAUTIONS: Hypersensitivity reactions have been reported with ELOCTATE. Allergic-type hypersensitivity reactions, including anaphylaxis, have been reported with Factor VIII replacement products.Full Important Safety Information
Please call 1-800-745-4447, Option 5, or complete the form below.
By submitting the following information, you are acknowledging that you understand that the information you provide may be used by Sanofi Genzyme US and their affiliates, and the business service companies working with Sanofi Genzyme US to provide you with additional communications and to develop products and services, which may include market research.